Hepatitis C virus related fatty liver

Liver steatosis is a prominent pathological feature of chronic hepatitis C (CHC). Increased lipid uptake and lipid synthesis and decreased lipid secretion and lipid degradation are all involved in the pathogenesis of steatosis induced by hepatitis C virus (HCV) infection. In this paper, the associat...

Full description

Bibliographic Details
Main Authors: ZHANG Yu, CHENG Jun
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2015-07-01
Series:Linchuang Gandanbing Zazhi
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=6632
id doaj-fdaf3ebb59664cc498fd4f28e93eef7c
record_format Article
spelling doaj-fdaf3ebb59664cc498fd4f28e93eef7c2020-11-24T22:27:23ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562015-07-013171034103710.3969/j.issn.1001-5256.2015.07.009Hepatitis C virus related fatty liverZHANG Yu0CHENG Jun1Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, ChinaInstitute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, ChinaLiver steatosis is a prominent pathological feature of chronic hepatitis C (CHC). Increased lipid uptake and lipid synthesis and decreased lipid secretion and lipid degradation are all involved in the pathogenesis of steatosis induced by hepatitis C virus (HCV) infection. In this paper, the association between HCV infection and liver steatosis is expounded. It is pointed out that the CHC patients with genotype 3 HCV infection have a higher incidence rate of liver steatosis than those with other genotypes, and studies have shown that it is closely related to the direct action of HCV. And for CHC patients with other genotypes, liver steatosis is mostly associated with metabolic disorder. Liver steatosis not only accelerates the process of chronic viral hepatitis, but also directly affects patients' response to antiviral therapy. The association between HCV infection and liver steatosis and the mechanism still need to be confirmed by further studies.http://www.lcgdbzz.org/qk_content.asp?id=6632
collection DOAJ
language zho
format Article
sources DOAJ
author ZHANG Yu
CHENG Jun
spellingShingle ZHANG Yu
CHENG Jun
Hepatitis C virus related fatty liver
Linchuang Gandanbing Zazhi
author_facet ZHANG Yu
CHENG Jun
author_sort ZHANG Yu
title Hepatitis C virus related fatty liver
title_short Hepatitis C virus related fatty liver
title_full Hepatitis C virus related fatty liver
title_fullStr Hepatitis C virus related fatty liver
title_full_unstemmed Hepatitis C virus related fatty liver
title_sort hepatitis c virus related fatty liver
publisher Editorial Department of Journal of Clinical Hepatology
series Linchuang Gandanbing Zazhi
issn 1001-5256
1001-5256
publishDate 2015-07-01
description Liver steatosis is a prominent pathological feature of chronic hepatitis C (CHC). Increased lipid uptake and lipid synthesis and decreased lipid secretion and lipid degradation are all involved in the pathogenesis of steatosis induced by hepatitis C virus (HCV) infection. In this paper, the association between HCV infection and liver steatosis is expounded. It is pointed out that the CHC patients with genotype 3 HCV infection have a higher incidence rate of liver steatosis than those with other genotypes, and studies have shown that it is closely related to the direct action of HCV. And for CHC patients with other genotypes, liver steatosis is mostly associated with metabolic disorder. Liver steatosis not only accelerates the process of chronic viral hepatitis, but also directly affects patients' response to antiviral therapy. The association between HCV infection and liver steatosis and the mechanism still need to be confirmed by further studies.
url http://www.lcgdbzz.org/qk_content.asp?id=6632
work_keys_str_mv AT zhangyu hepatitiscvirusrelatedfattyliver
AT chengjun hepatitiscvirusrelatedfattyliver
_version_ 1725750229310898176